Genesco (GCO) Tops Q2 EPS by $1.06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GCO Hot Sheet
Price: $39.30 +7.58%
Revenue Growth %: +0.2%
Financial Fact:
Total interest expense, net: 1.49M
Today's EPS Names:
COHR, ATS, SICP, More
Revenue Growth %: +0.2%
Financial Fact:
Total interest expense, net: 1.49M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Genesco (NYSE: GCO) reported Q2 EPS of $1.05, $1.06 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $555 million versus the consensus estimate of $517.76 million.
For earnings history and earnings-related data on Genesco (GCO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Solid Biosciences (SLDB) Tops Q3 EPS by 5c
- Relay Therapeutics, Inc. (RLAY) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
